(Q38108689)

29 August 2017

0 references

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis (English)

1 reference

29 August 2017

0 references

0 references

1 reference

5

Gavin Giovannoni

1 reference

29 August 2017

Eleanor James

1

1 reference

29 August 2017

Ruth Dobson

2

1 reference

29 August 2017

Jens Kuhle

3

1 reference

29 August 2017

David Baker

4

1 reference

29 August 2017

Sreeram V Ramagopalan

6

1 reference

29 August 2017

publication date

22 May 2013

1 reference

Multiple Sclerosis Journal

29 August 2017

published in

1 reference

29 August 2017

volume

19

1 reference

29 August 2017

issue

12

1 reference

29 August 2017

page(s)

1571-1579

1 reference

Revised estimate of the prevalence of multiple sclerosis in the united states

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Vitamin D2 is much less effective than vitamin D3 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

Optimal Serum 25-Hydroxyvitamin D Levels for Multiple Health Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513489756

21 January 2018

Identifiers

DOI

10.1177/1352458513489756

1 reference

29 August 2017

1 reference